Also known as

Afamelanotide (related approved context) · Melanotan-I · NDP-MSH

Overview

MT-1 (Melanotan-1 / NDP-MSH) is a melanocortin agonist studied in melanogenesis and UV-response research. Related afamelanotide literature informs pigmentation and photoprotection model design.

Catalog interest is primarily MC1R-driven pigment biology. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Melanogenesis endpoints in pigment-cell models

• • UV-response and photoprotection research markers

• • MC1R agonist pharmacology

• • Comparative pigmentation work versus Melanotan-2

• • Melanin-density and tanning-response readouts where studied

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early melanocortin or gonadal-axis signaling in acute models.

• • Week 3–4: Clearer arousal, pigmentation, or hormone-axis markers in short research windows.

• • Month 2–3: More stable pathway and behavioral endpoints in extended preclinical designs.

• • Month 3–6: Sustained melanocortin or reproductive-axis observations where longer windows are used.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.